E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/15/2005 in the Prospect News Biotech Daily.

Cytori Therapeutics to trade on Nasdaq Capital Market starting Monday

New York, Dec. 15 - Cytori Therapeutics, Inc. said its common stock will begin trading on the Nasdaq Capital Market on Monday.

The ticker symbol will be "CYTX."

The San Diego-based pharmaceutical company's stock will continue to trade on the Frankfurt exchange under the symbol "XMPA."


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.